Artemis Investment Management LLP Bristol Myers Squibb CO Transaction History

Artemis Investment Management LLP

$6.17 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $95 Million - $106 Million	-1,491,822 Reduced 97.36%	40,486 $2.59 Million
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $23.1 Million - $26.2 Million	-351,232 Reduced 18.65%	1,532,308 $106 Million
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $7.9 Million - $9.36 Million	-115,421 Reduced 5.77%	1,883,540 $0
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $5,400 - $3.19 Million	41,541 Added 2.12%	1,998,961 $142 Million
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $2.1 Million - $2.32 Million	-28,979 Reduced 1.46%	1,957,420 $151 Million
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $122 Million - $146 Million	1,986,399 New	1,986,399 $145 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $10.5 Million - $12.2 Million	-195,224 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $3.8 Million - $4.45 Million	64,214 Added 49.01%	195,224 $11.5 Million
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $47 Million - $51.1 Million	-758,402 Reduced 85.27%	131,010 $8.76 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $6.59 Million - $7.41 Million	-111,070 Reduced 11.1%	889,412 $56.1 Million
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $2.31 Million - $2.62 Million	-40,055 Reduced 3.85%	1,000,482 $62.1 Million
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $10.1 Million - $11.2 Million	-176,545 Reduced 14.51%	1,040,537 $62.7 Million
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $32.7 Million - $38.2 Million	-596,786 Reduced 32.9%	1,217,082 $71.8 Million
Q1 2020 Apr 14, 2020	BUY	$46.4 - $67.43 $29.6 Million - $42.9 Million	636,863 Added 54.11%	1,813,868 $101 Million
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $42.2 Million - $55 Million	856,705 Added 267.47%	1,177,005 $75.4 Million
Q3 2019 Oct 10, 2019	BUY	$42.77 - $50.71 $3.64 Million - $4.31 Million	85,000 Added 36.12%	320,300 $16.2 Million
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $11.2 Million - $12.4 Million	-252,000 Reduced 51.71%	235,300 $10.6 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $44.9 Million - $53.5 Million	-994,581 Reduced 67.12%	487,300 $23.3 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $72.3 Million - $93.7 Million	1,481,881 New	1,481,881 $77 Million
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $9.98 Million - $10.9 Million	-166,500 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $469,455 - $541,790	8,500 Added 5.38%	166,500 $10.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	158,000	158,000 $8.81 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.15 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.36 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.52 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Account